385 related articles for article (PubMed ID: 9895383)
41. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin.
Cuillière C; Ducrotté P; Zerbib F; Metman EH; de Looze D; Guillemot F; Hudziak H; Lamouliatte H; Grimaud JC; Ropert A; Dapoigny M; Bost R; Lémann M; Bigard MA; Denis P; Auget JL; Galmiche JP; Bruley des Varannes S
Gut; 1997 Jul; 41(1):87-92. PubMed ID: 9274478
[TBL] [Abstract][Full Text] [Related]
42. High-resolution manometry is comparable to timed barium esophagogram for assessing response to pneumatic dilation in patients with achalasia.
Ghoshal UC; Gupta M; Verma A; Neyaz Z; Mohindra S; Misra A; Saraswat VA
Indian J Gastroenterol; 2015 Mar; 34(2):144-51. PubMed ID: 25911464
[TBL] [Abstract][Full Text] [Related]
43. Assessment of esophageal emptying post-pneumatic dilation: use of the timed barium esophagram.
Vaezi MF; Baker ME; Richter JE
Am J Gastroenterol; 1999 Jul; 94(7):1802-7. PubMed ID: 10406238
[TBL] [Abstract][Full Text] [Related]
44. Outcomes of pneumatic dilation in achalasia: Extended follow-up of more than 25 years with a focus on manometric subtypes.
Müller M; Keck C; Eckardt AJ; Werling S; Wehrmann T; König J; Gockel I
J Gastroenterol Hepatol; 2018 May; 33(5):1067-1074. PubMed ID: 29140553
[TBL] [Abstract][Full Text] [Related]
45. Short and medium-term therapeutic effects of pneumatic dilatation for achalasia: a 15-year tertiary centre experience.
Andreevski V; Nojkov B; Krstevski M; Genadieva Dimitrova M; Joksimovik N; Serafimoski V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(2):15-22. PubMed ID: 24285349
[TBL] [Abstract][Full Text] [Related]
46. Long-term effects of pneumatic dilatation on symptoms and lower oesophageal sphincter pressure in achalasia.
Penagini R; Cantù P; Mangano M; Colombo P; Bianchi PA
Scand J Gastroenterol; 2002 Apr; 37(4):380-4. PubMed ID: 11989826
[TBL] [Abstract][Full Text] [Related]
47. Intrasphincteric injection of botulinum toxin is effective in long-term treatment of esophageal achalasia.
Annese V; Basciani M; Borrelli O; Leandro G; Simone P; Andriulli A
Muscle Nerve; 1998 Nov; 21(11):1540-2. PubMed ID: 9771683
[TBL] [Abstract][Full Text] [Related]
48. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study.
Kolbasnik J; Waterfall WE; Fachnie B; Chen Y; Tougas G
Am J Gastroenterol; 1999 Dec; 94(12):3434-9. PubMed ID: 10606299
[TBL] [Abstract][Full Text] [Related]
49. Long-term follow-up of achalasic patients treated with botulinum toxin.
D'Onofrio V; Annese V; Miletto P; Leandro G; Marasco A; Sodano P; Iaquinto G
Dis Esophagus; 2000; 13(2):96-101; discussion 102-3. PubMed ID: 14601898
[TBL] [Abstract][Full Text] [Related]
50. Treatment of achalasia with botulinum toxin.
López P; Castiella A; Montalvo I; Bujanda L; Alzate LF; Gil I; Arenas JI
Rev Esp Enferm Dig; 1997 May; 89(5):367-74. PubMed ID: 9190142
[TBL] [Abstract][Full Text] [Related]
51. Botulinum toxin for achalasia: long-term outcome and predictors of response.
Pasricha PJ; Rai R; Ravich WJ; Hendrix TR; Kalloo AN
Gastroenterology; 1996 May; 110(5):1410-5. PubMed ID: 8613045
[TBL] [Abstract][Full Text] [Related]
52. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.
Annese V; Bassotti G; Coccia G; Dinelli M; D'Onofrio V; Gatto G; Leandro G; Repici A; Testoni PA; Andriulli A
Gut; 2000 May; 46(5):597-600. PubMed ID: 10764700
[TBL] [Abstract][Full Text] [Related]
53. Lower oesophageal sphincter pressure and timed barium oesophagogram: two objective parameters in the non-invasive assessment of primary achalasia.
Montazeri G; Nouri N; Estakhri A; Shirani S; Derakhshan MH; Yaghoobi M; Mikaeli J; Malekzadeh R
Aliment Pharmacol Ther; 2005 Aug; 22(3):261-5. PubMed ID: 16091064
[TBL] [Abstract][Full Text] [Related]
54. Treatment of achalasia: recent advances in surgery.
Seelig MH; DeVault KR; Seelig SK; Klingler PJ; Branton SA; Floch NR; Bammer T; Hinder RA
J Clin Gastroenterol; 1999 Apr; 28(3):202-7. PubMed ID: 10192604
[TBL] [Abstract][Full Text] [Related]
55. Impact of preoperative balloon dilatation on outcomes of laparoscopic surgery in young patients with esophageal achalasia.
Tsuboi K; Omura N; Yano F; Hoshino M; Yamamoto SR; Akimoto S; Masuda T; Kashiwagi H; Yanaga K
Esophagus; 2018 Jan; 15(1):39-46. PubMed ID: 29892807
[TBL] [Abstract][Full Text] [Related]
56. Two cases of severe non-specific oesophageal dysmotility showing different response to botulinum injection therapy.
Suresh RL; Kulhalli V; Evans D; Guinane M; Ainley C
Med J Malaysia; 2000 Sep; 55(3):379-81. PubMed ID: 11200722
[TBL] [Abstract][Full Text] [Related]
57. Treatment choices and outcomes of patients with manometrically diagnosed achalasia.
Yeung JC; Finley C; Hanna WC; Miller L; Ferri L; Urbach DR; Darling GE
Dis Esophagus; 2016 Jul; 29(5):472-8. PubMed ID: 25809620
[TBL] [Abstract][Full Text] [Related]
58. Predictors for outcome of failure of balloon dilatation in patients with achalasia.
Alderliesten J; Conchillo JM; Leeuwenburgh I; Steyerberg EW; Kuipers EJ
Gut; 2011 Jan; 60(1):10-6. PubMed ID: 21068135
[TBL] [Abstract][Full Text] [Related]
59. Review article: the management of achalasia - a comparison of different treatment modalities.
Lake JM; Wong RK
Aliment Pharmacol Ther; 2006 Sep; 24(6):909-18. PubMed ID: 16948803
[TBL] [Abstract][Full Text] [Related]
60. Forceful dilatation under endoscopic control in the treatment of achalasia: a randomised trial of pneumatic versus metallic dilator.
Mearin F; Armengol JR; Chicharro L; Papo M; Balboa A; Malagelada JR
Gut; 1994 Oct; 35(10):1360-2. PubMed ID: 7959186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
